FUJIFILM Sonosite Introduces PIV Assist, an AI-Powered Ultrasound Feature to Support Peripheral IV Procedures

New AI-driven vascular access tool offers real-time vessel identification

BOTHELL, Wash.--(BUSINESS WIRE)--FUJIFILM Sonosite, Inc., a global leader in point-of-care ultrasound (POCUS) solutions, announces the launch of PIV Assist, a new AI-powered feature designed to assist clinicians in planning peripheral intravenous (PIV) access procedures. The feature will be available on Sonosite LX, Sonosite PX, and Sonosite ST ultrasound systems.

"Peripheral IV procedures are among the most common performed on patients, and growing evidence supports ultrasound-guided insertion as a helpful technique, especially for those with difficult IV access¹,” said Richard Fabian, president and CEO of FUJIFILM Sonosite, Inc. “At Sonosite, we have a long history of innovation in both education and product development. PIV Assist is an AI-powered tool we developed in close collaboration with our customers. It’s designed to reduce cognitive load and enhance clinician confidence during vascular access planning - both of which are critical to delivering effective patient care”.

PIV Assist supports users by aiding in the identification of candidate veins and assessing vein size to provide feedback on the maximum cannula size based on the catheter-to-vein ratio (CVR). By delivering real-time differentiation between veins and arteries during the pre-scan, PIV Assist aims to support clinical workflow during vascular access planning.

Key functionalities of PIV assist include:

• Color-coded guidance: Veins are color-coded according to the maximum recommended catheter gauge, with arteries marked in red to assist procedural planning
• CVR visualization: The feature calculates and displays the catheter-to-vein ratio in real-time and shows the depth to the center of the vein
• Workflow support: PIV Assist is intended to support procedural efficiency and clinician confidence
• Wide platform availability: PIV Assist is offered as a licensed feature across Sonosite LX, PX, and ST systems
• Robust algorithm training: The AI model was developed using tens of thousands of scan images, designed to provide reliable vessel identification support

To learn more about this exciting new feature, click here.

1-	Bruant A, Normand L. Recent Advances in Ultrasound-Guided Peripheral Intravenous Catheter Insertion. Nurs Rep. 2025 Oct 8;15(10):359. doi: 10.3390/nursrep15100359. PMID: 41149674; PMCID: PMC12566756.

About Fujifilm

FUJIFILM Sonosite, Inc. is the innovator and world leader in bedside and point-of-care ultrasound, and an industry leader in ultra-high frequency micro-ultrasound technology. Headquartered near Seattle, the company is represented by a global distribution network in over 100 countries. Sonosite’s portable, compact systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high-performance ultrasound to the point of patient care. For more information, please visit www.sonosite.com.

FUJIFILM Holdings Corporation, headquartered in Tokyo, leverages its depth of knowledge and proprietary core technologies to deliver innovative products and services across the globe through the four key business segments of healthcare, electronics, business innovation, and imaging with over 70,000 employees. Guided and united by our Group Purpose of “giving our world more smiles,” we address social challenges and create a positive impact on society through our products, services, and business operations. Under its medium-term management plan, VISION2030, which ends in FY2030, we aspire to continue our evolution into a company that creates value and smiles for various stakeholders as a collection of global leading businesses and achieve a global revenue of 4 trillion yen. For more information, please visit: https://holdings.fujifilm.com/en.